DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Sign in and take the values quiz to see how this bill lines up with what you've said.
This bill establishes postmarket reporting requirements for pharmaceutical manufacturers and modifies rules of origin for active pharmaceutical ingredients in federal procurement. Drug manufacturers must annually report the names, addresses, and sourcing percentages of all active and inactive ingredients to the FDA, with aggregated information published publicly and shared with the Department of Defense. The bill also amends FDA inspection protocols to consider whether establishments have been inspected by foreign adversaries, the criticality of drugs manufactured, and whether they are located in countries with histories of exporting illicit drugs.
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
Sign in to see how your representatives voted on this bill.